Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal

Ante Mihaljevic1,2, Philip D Rubin1,2, Panagiotis Chouvardas3,4

  • 1Department for BioMedical Research, University of Bern, 3008, Bern, Switzerland.

Scientific Reports
|May 13, 2024
PubMed

Insights

Long non-coding RNAs (lncRNAs) are highly cell-type specific in colorectal cancer (CRC). Researchers identified novel lncRNA targets, like CASC19 and LINC00460, for potential CRC therapeutics.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in human cancers.
  • Functional studies of lncRNAs in cancer cell subtypes are limited, with a focus on protein-coding genes.
  • Understanding lncRNA contributions to Colorectal Cancer (CRC) heterogeneity is crucial.

Purpose of the Study:

  • To explore the role and specificity of lncRNAs in Colorectal Cancer (CRC) heterogeneity.
  • To identify novel lncRNAs enriched in CRC epithelial cells and differentially expressed in tumors.
  • To experimentally validate the functional significance of specific lncRNAs in CRC proliferation.

Main Methods:

  • Single-cell RNA sequencing of 49,436 cells from 29 CRC patients.
  • Analysis of lncRNA cell-type specificity compared to protein-coding genes.
  • Integration of bulk CRC expression data (270 profiles) to identify differentially expressed lncRNAs.
  • Experimental validation of CASC19 and LINC00460 in CRC cell lines using CRISPR-Cas9 knockdown.

Main Results:

  • lncRNAs demonstrated significantly higher cell-type specificity than protein-coding genes in CRC.
  • 996 lncRNAs were identified as highly enriched in epithelial cells.
  • 98 of these lncRNAs were differentially expressed in tumor versus normal CRC tissues.
  • Upregulation of CASC19 and LINC00460 was confirmed, and their knockdown affected CRC proliferation.

Conclusions:

  • lncRNAs play a significant role in CRC heterogeneity and exhibit distinct cell-type specific expression patterns.
  • CASC19 and LINC00460 are identified as novel, upregulated lncRNAs implicated in CRC proliferation.
  • These findings highlight potential new RNA-based therapeutic targets for Colorectal Cancer.